Dynavax Technologies Corporation (DVAX), headquartered in Emeryville, California, is a biopharmaceutical innovator focused on developing next-generation vaccines and immunotherapies for critical public health issues. The company’s flagship product, HEPLISAV-B, is an advanced and efficacious hepatitis B vaccine that has garnered regulatory approval in the United States and various international markets. With a promising product pipeline and strategic collaborations, Dynavax is well-positioned to drive significant advancements in vaccine technology and address substantial unmet medical needs globally. Its commitment to innovation not only enhances the quality of care but also establishes Dynavax as a key player within the evolving landscape of the vaccine industry. Show more

Location: 2100 POWELL STREET, EMERYVILLE, CA, UNITED STATES, 94608, Suite 900, EmeryVille, CA, 94608, USA | Website: https://www.dynavax.com | Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC | Sector: HEALTHCARE

Market Cap

1.818B

52 Wk Range

$9.20 - $15.73

Previous Close

$15.48

Open

$15.48

Volume

1,559,096

Day Range

$15.47 - $15.50

Enterprise Value

1.46B

Cash

160.2M

Avg Qtr Burn

N/A

Insider Ownership

0.75%

Institutional Own.

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
MVC-COV1901 Details COVID-19 Vaccine	Approved Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Heplisav-B Details Infectious disease, Hepatitis B vaccine, Hepatitis B	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CpG 1018 Details COVID-19	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
COVID-19 S-Trimer (with Clover Biopharmaceuticals) Details Infectious disease, COVID-19	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Heplisav-B Details Infectious disease, Hepatitis B vaccine, Hepatitis B	BLA Resubmission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Vaxart Oral COVID-19 Vaccine (Oral Vaccine) Details COVID-19	Phase 2b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
(rF1V) vaccine (adjuvanted w/ CpG 1018) Details Plague	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CpG 1018 Details Pandemic influenza vaccines	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Z-1018 (adjuvanted w/ CpG 1018) Details Shingles Vaccine	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Tdap-1018 (adjuvanted w/ CpG 1018) Details Infectious disease, Tetanus, diphtheria, and pertussis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VLA2001 Details Infectious disease, COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.